Company: CERO
Filing Date: 2025-09-04
Form Type: 8-K
Source: 0001213900-25-084498
Chunk: 0

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-09-04
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.

On August 28, 2025, CERo
Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), received a letter from the staff at the
Nasdaq Listing Qualifications department notifying the Company that such staff had determined that the Company does not comply with the
minimum stockholders’ equity requirement of $2,500,000 (the “Stockholders’ Equity Requirement”)
for continued listing on the Nasdaq Capital Market (“Nasdaq”) set forth in Nasdaq Rule 5550(b).